Related Experiment Video
Updated: Jun 8, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Cardioprotective PKG-independent NO signaling at reperfusion
Michael V Cohen1, Xi-Ming Yang, Yanping Liu
1Department of Physiology, University of South Alabama College of Medicine, Mobile, Alabama 36688, USA. mcohen@usouthal.edu
Abstract:
Cell models of ischemic preconditioning (IPC) indicate nitric oxide (NO) is involved in protection accruing during reoxygenation but disagree whether it acts through PKG. Using a more relevant intact heart model, we studied isolated rabbit hearts subjected to 30-min coronary artery occlusion/120-min reperfusion. We previously found protection from PKG activator 8-(4-chlorophenylthio)-guanosine 3',5'-cyclic monophosphate (CPT-cGMP) at reperfusion was blocked by A(2b) adenosine receptor (A(2b)AR), ERK, or phosphatidylinositol 3-kinase (PI3-kinase) blockers. In this investigation A(2b)AR agonist BAY 60-6583 or CPT-cGMP at reperfusion reduced infarction comparably to IPC. Their protection was abrogated by N(ω)-nitro-l-arginine methyl ester (l-NAME), suggesting a PKG-independent NO synthase in IPC's mediator pathway downstream of PKG and A(2b)AR. NO donor S-nitroso-N-acetyl-d,l-penicillamine (SNAP) at reperfusion also protected. This protection was not blocked by PI3-kinase inhibitor wortmannin or ERK antagonist PD-98059, suggesting NO acted downstream of these kinases. Protection from SNAP was not affected by mitochondrial ATP-sensitive K(+) channel closer 5-hydroxydecanoate, PKC antagonist chelerythrine, reactive oxygen species scavenger N-2-mercaptopropionylglycine, or soluble guanylyl cyclase antagonist 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). Absence of ODQ effect indicated NO was acting independently of PKG. BAY 58-2667, a soluble guanylyl cyclase activator, was protective, and l-NAME blocked its infarct-sparing effect, indicating a second signaling event dependent on NO generation but independent of PKG. SB216763, a blocker of glycogen synthase kinase-3β (GSK-3β), decreased infarct size, and its infarct-sparing effect was not affected by l-NAME, suggesting GSK-3β acted downstream or independently of NO. Hence, NO signaling occurs in IPC's mediator pathway downstream of Akt and ERK, and its protection is independent of PKG.
Insights
Nitric oxide (NO) protects the heart during reperfusion independently of PKG, acting downstream of ERK and PI3-kinase. This NO signaling pathway is crucial for ischemic preconditioning (IPC) in intact hearts.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Ischemic Heart Disease
Background:
- Ischemic preconditioning (IPC) offers cardiac protection during reperfusion, with nitric oxide (NO) implicated.
- Previous cell models yielded conflicting results regarding NO's role via protein kinase G (PKG).
- A more physiologically relevant intact heart model is needed to clarify NO's signaling pathway in IPC.
Purpose of the Study:
- To investigate the role of nitric oxide (NO) and its signaling pathways in mediating protection during ischemic preconditioning (IPC) in an intact rabbit heart model.
- To determine if NO acts independently of protein kinase G (PKG) and downstream of specific kinases like ERK and PI3-kinase.
Main Methods:
- Isolated rabbit hearts subjected to 30-min coronary artery occlusion followed by 120-min reperfusion.
- Administration of A(2b) adenosine receptor (A(2b)AR) agonist (BAY 60-6583), PKG activator (CPT-cGMP), and NO donor (SNAP) at reperfusion.
- Use of pharmacological inhibitors: N(ω)-nitro-l-arginine methyl ester (l-NAME) for NO synthase, wortmannin for PI3-kinase, PD-98059 for ERK, and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) for soluble guanylyl cyclase.
Main Results:
- Both A(2b)AR agonist and CPT-cGMP reduced infarct size, with protection abolished by l-NAME, indicating a PKG-independent NO synthase.
- NO donor SNAP also protected against infarction, independent of PI3-kinase and ERK inhibitors, suggesting NO acts downstream of these kinases.
- NO-mediated protection was independent of PKG, as shown by the lack of effect of ODQ, and involved a second signaling event dependent on NO generation.
Conclusions:
- Nitric oxide (NO) plays a significant role in the protective mechanisms of ischemic preconditioning (IPC) in intact hearts.
- NO signaling occurs downstream of ERK and PI3-kinase pathways and is independent of protein kinase G (PKG).
- This study elucidates a novel NO-dependent, PKG-independent signaling cascade critical for cardiac protection during reperfusion.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
